JPMorgan Chase & Co’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Buy |
102,917
+17,427
| +20% | +$167K | ﹤0.01% | 3738 |
|
|
2025
Q1 | $795K | Sell |
85,490
-5,625
| -6% | -$52.3K | ﹤0.01% | 3776 |
|
|
2024
Q4 | $1.27M | Sell |
91,115
-277,532
| -75% | -$3.86M | ﹤0.01% | 3652 |
|
|
2024
Q3 | $8.67M | Buy |
368,647
+3,896
| +1% | +$91.6K | ﹤0.01% | 2251 |
|
|
2024
Q2 | $5.83M | Sell |
364,751
-15,846
| -4% | -$253K | ﹤0.01% | 2440 |
|
|
2024
Q1 | $6.24M | Sell |
380,597
-21,109
| -5% | -$346K | ﹤0.01% | 2425 |
|
|
2023
Q4 | $5.56M | Buy |
401,706
+4,088
| +1% | +$56.6K | ﹤0.01% | 2488 |
|
|
2023
Q3 | $5.48M | Sell |
397,618
-25,803
| -6% | -$355K | ﹤0.01% | 2367 |
|
|
2023
Q2 | $7.21M | Buy |
423,421
+230,912
| +120% | +$3.93M | ﹤0.01% | 2269 |
|
|
2023
Q1 | $3.09M | Sell |
192,509
-6,698
| -3% | -$108K | ﹤0.01% | 2752 |
|
|
2022
Q4 | $1.51M | Sell |
199,207
-20,340
| -9% | -$154K | ﹤0.01% | 3134 |
|
|
2022
Q3 | $1.93M | Sell |
219,547
-4,945
| -2% | -$43.5K | ﹤0.01% | 2940 |
|
|
2022
Q2 | $1.61M | Sell |
224,492
-3,990
| -2% | -$28.5K | ﹤0.01% | 3152 |
|
|
2022
Q1 | $2.45M | Buy |
228,482
+73,903
| +48% | +$791K | ﹤0.01% | 3044 |
|
|
2021
Q4 | $2.18M | Buy |
+154,579
| New | +$2.18M | ﹤0.01% | 3178 |
|